Multiple Sclerosis News from Medical News Today

Multiple Sclerosis News

Multiple Sclerosis News

The latest Multiple Sclerosis News articles published daily. Includes news on multiple sclerosis (MS), encephalomyelitis disseminata (ED), myelin and nerve fibers.

Add this Multiple Sclerosis rss news feed to your rss reader:

Latest News

Insight Into How Brain Stem Cells Develop Into Cells Which Repair Damaged Tissue

03 July 2009

The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of...
[read article]

UCB And Biogen Idec Discontinue Phase II Clinical Trial Of CDP323 - Analysis Showed No Clinically Relevant Benefit For Patients

02 July 2009

UCB and Biogen Idec announced today the discontinuation of the Phase II clinical trial of CDP323 for the treatment of relapsing multiple sclerosis (MS). Preliminary interim efficacy analysis showed that patients enrolled in...
[read article]

Hard To Treat Diseases (HTDS) Clinical Trial Update On Therapeutic Effects Of Combined Treatment With Ribavirin And Tiazofurin

02 July 2009

Hard To Treat Diseases (HTDS) Chief Scientist with its Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on recent clinical trials with animal subjects in regards to the use of Ribavirin And Tiazofurin for the...
[read article]

Multiple Sclerosis News Articles Archive - Page 1

02 July 2009

Important Modulator Of Immune Cell Entry Into The Brain Discovered

01 July 2009

UCB And Biogen Idec Discontinue Phase II Clinical Trial Of CDP323

29 June 2009

New Control System Of The Body Discovered - Important Modulator Of Immune Cell Entry Into The Brain - Perhaps New Target For The Therapy

24 June 2009

Biogen Idec Announces First Patient Enrolled In The Global Phase III Study Of PEGylated Interferon Beta-1a For Relapsing Multiple Sclerosis

23 June 2009

Smoking Linked To Brain Damage, New Study

Multiple Sclerosis Treatment Pioneer's Helium Suicide

Figuring Out Who Will Benefit Most From A New Therapy For Multiple Sclerosis

Two Studies Report Finding New Genes And Gene Regions That Make People Susceptible To MS

Multiple Sclerosis: Hope Through New Oral Therapeutics

Fingolimod And Cladribine: Two New Oral Substances Show Promising Results In Current Clinical Trials For MS Therapy

19 June 2009

Announcing National MS And Parkinson's Disease Registries Act

18 June 2009

New Study Finds 1 In 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions

17 June 2009

Researchers Piece Together More Of The Multiple Sclerosis Genetic Code

15 June 2009

Aussie And Kiwi Researchers Make Double MS Genetic Discovery

Queensland Researchers Help Unlock Genetic Keys To MS

MS Society Commends Federal Government's Research Investment In Neurological Diseases

Prevalence Of Multiple Sclerosis In The United Kingdom - Study Estimates Now 100,000 People With MS In UK

14 June 2009

Tracking Down The Causes Of Multiple Sclerosis - New Discoveries In Immune Response

MS Society Commends Federal Government's Research Investment In Neurological Diseases

Numbers Of People With MS Higher Than Previously Estimated

12 June 2009

Stem Cell Transplant Study Shows Promise For Multiple Sclerosis

Study: Breastfeeding May Reduce Likelihood Of Postpartum MS Attacks

11 June 2009

Multiple Sclerosis: Tracking Down The Causes

Redefining How A Chronic Auto-Immune Disease Is Diagnosed

09 June 2009

Breastfeeding Associated With A Reduced Risk Of Relapse In Women With Multiple Sclerosis

08 June 2009

MS Society Supports National Carers Week, UK

06 June 2009

A New Lead For Autoimmune Disease

05 June 2009

Hydrangea Root Shows Promise In Treating Autoimmune Disorders

03 June 2009

Secretary Of State Backs MS Society Work Retention Project

31 May 2009

BioPartners GmbH Withdraws Its Application For Biferonex (interferon Beta-1a)

29 May 2009

MS Patients Report Greater Treatment Satisfaction With TYSABRI

28 May 2009

Prescribing Sunshine For Multiple Sclerosis?

One Size Does Not Fit All: A New Look At Therapies

MS Society Scotland Supports Shine On Scotland Campaign

Link Between Vitamin D And Reduction In Multiple Sclerosis Risk

27 May 2009

Multiple Sclerosis Patients Benefit From Diabetes Drug

American Woman Becomes First Person With Diagnosed Multiple Sclerosis To Reach The Top Of MT Everest

26 May 2009

Positive Clinical Trial Results Take Center Stage At American Academy Of Neurology Meeting

25 May 2009

Almirall Announces Filing Sativex(R) - For Treatment Of Spasticity In Multiple Sclerosis - Regulatory Submission

22 May 2009

News From The American Journal Of Pathology, June 2009

MS Societies In UK And Australia Provide International Research Opportunity

21 May 2009

When Managed By Specialty Pharmacy, MS Patients More Compliant With Medications

18 May 2009

Establishment Of Five New Multiple Sclerosis Research Centres In Canada

15 May 2009

Five Multiple Sclerosis Research Centres Established

13 May 2009

Researchers Identify Pathway To Reactivate Myelin Repair

New MS Drugs Growing In Popularity But Are They Increasing The Risk Of Cancer?

11 May 2009

MS Society Statement On Oral Therapy Results

09 May 2009

United Spinal Association Reports Positive Results Of Stem Cell Transplantation To Treat Multiple Sclerosis: Study May Be Key To Unlocking A Cure

08 May 2009

Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought

05 May 2009

Setbacks In Patients With Relapsing-Remitting Multiple Sclerosis Can Be Reduced If Methylprednisolone Is Added To Interferon Beta

04 May 2009

First Ten-Year Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients

03 May 2009

Study Highlights Economic Impact Of Early Mobility Impairment In People With Multiple Sclerosis

02 May 2009

Two-Year Phase III Data Presented At AAN 61st Annual Meeting Show Positive Outcome Of Cladribine Tablets In Patients With Multiple Sclerosis

New Data Presented At American Academy Of Neurology Congress Show 80-83% Of MS Patients On Oral FTY720 Were Relapse-free For One Year

New Data Illustrate Novel Mechanism of Action of Laquinimod, An Oral Compound For The Treatment of Multiple Sclerosis

First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients

MRI Data Showing Tysabri® Promoted Remyelination Presented At The 61st Annual Meeting Of The American Academy Of Neurology

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]

Multiple Sclerosis News

Latest News

Multiple Sclerosis News Articles Archive - Page 1

Swine Flu Updates